The activation of the angiotensin II system (Ang II) and nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase) in obesity results in cardiovascular disease, hypertension, and diabetes [70,71]. This evidence concerns the gene FMO5 and obesity due to melanocortin 4 receptor deficiency.